Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Transgenic rescue of insulin receptor–deficient mice
Haruka Okamoto, … , Ioannis Dragatsis, Domenico Accili
Haruka Okamoto, … , Ioannis Dragatsis, Domenico Accili
Published July 15, 2004
Citation Information: J Clin Invest. 2004;114(2):214-223. https://doi.org/10.1172/JCI21645.
View: Text | PDF
Article Metabolism

Transgenic rescue of insulin receptor–deficient mice

  • Text
  • PDF
Abstract

The role of different tissues in insulin action and their contribution to the pathogenesis of diabetes remain unclear. To examine this question, we have used genetic reconstitution experiments in mice. Genetic ablation of insulin receptors causes early postnatal death from diabetic ketoacidosis. We show that combined restoration of insulin receptor function in brain, liver, and pancreatic β cells rescues insulin receptor knockout mice from neonatal death, prevents diabetes in a majority of animals, and normalizes adipose tissue content, lifespan, and reproductive function. In contrast, mice with insulin receptor expression limited to brain or liver and pancreatic β cells are rescued from neonatal death, but develop lipoatrophic diabetes and die prematurely. These data indicate, surprisingly, that insulin receptor signaling in noncanonical insulin target tissues is sufficient to maintain fuel homeostasis and prevent diabetes.

Authors

Haruka Okamoto, Jun Nakae, Tadahiro Kitamura, Byung-Chul Park, Ioannis Dragatsis, Domenico Accili

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Pancreatic islet morphology. (A) We show the typical appearance of islet...
Pancreatic islet morphology. (A) We show the typical appearance of islets in 1-month-old mice from each of the Ttr-Insr lines. The upper two rows show immunostaining with anti-insulin and the lower two rows, with anti-glucagon antiserum. (B) Morphometric evaluation of β-cell mass. We determined α- and β-cell area by manually tracing immunoreactive cells in nonoverlapping fields from sections obtained at least 80 μm apart. We analyzed three sections per mouse and four mice per genotype. Area values were multiplied by total pancreas weight to obtain islet cell mass. (C) Altered islet size and morphology in 4-month-old L2 and L3 mice. The upper panels show double immunostaining with anti-insulin (red) and anti-glucagon (green) antisera. The lower panels show double immunohistochemistry with anti-insulin (red) and anti-Pdx1 (green) antisera.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts